Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania's consolidated general budget recorded a deficit of RON 14.23 billion (€2.86 billion) - 0.70% of GDP, in the first two months of 2026, half the RON 30.24 billion deficit (€2.86 billion) - 1.58% of GDP from the same period in 2025.
Electrica's Board of Directors has approved new four-year mandates for its top executive leadership following a meeting on 27 March.
Japan Credit Rating Agency (JCR) announced on Friday the reconfirmation of Romania's country rating at BBB (foreign currency) and BBB+ (local currency) and improved the outlook from negative to stable.
State-owned power producer Hidroelectrica achieved total investments of RON 781 million (€157 million) in 2025, up 32% compared to 2024, representing the company's best investment volume in years.
Verne, Pony.ai and Uber Technologies have announced a partnership to launch Europe's first commercial robotaxi service, beginning in Zagreb with initial deployment work already underway, including public-road validation.